首页> 外国专利> N- A lipophilic drug-loaded solid lipid nanoparticle surface-modified with N-trimethyl chitosan graft palmitic acid

N- A lipophilic drug-loaded solid lipid nanoparticle surface-modified with N-trimethyl chitosan graft palmitic acid

机译:N-三甲基壳聚糖接枝棕榈酸改性的N-亲脂性载药固体脂质纳米颗粒

摘要

The present invention relates to a lipid-soluble drug-containing solid lipid, which is surface-modified with an N-trimethylolchitosan bond-containing palmitic acid polymer, which comprises obtaining and mixing lipid-soluble drug-containing solid lipid nanoparticles The present invention relates to a method for producing nanoparticles, a lipid-soluble drug-containing solid lipid nanoparticle surface-modified with N-trimethylol chitosan-bound palmitic acid polymer prepared by the above method, and a preparation for oral administration of resveratrol in which resveratrol is encapsulated in the nanoparticles. The solid lipid nanoparticles encapsulated with the liposoluble drug of the present invention and surface-modified with the N-trimethylolchitosan bond-containing palmitic acid polymer are stable in an acidic gastric environment due to the coating of the polymer, so that even when orally administered, Release of the lipid-soluble drug, and thus the lipid-soluble drug can be effectively used as a preparation for oral administration of the lipid-soluble drug.;
机译:本发明涉及一种含脂溶性药物的固体脂质,其被含N-三羟甲基壳聚糖键的棕榈酸聚合物表面改性,其包括获得并混合含脂溶性药物的固体脂质纳米颗粒。纳米粒子的制造方法,通过上述方法制备的经N-三羟甲基壳聚糖结合的棕榈酸聚合物表面改性的含脂溶性药物的固体脂质纳米粒子,以及将白藜芦醇封装于其中的白藜芦醇的口服制剂纳米粒子。用本发明的脂溶性药物包封并用含N-三羟甲基壳聚糖键的棕榈酸聚合物进行表面改性的固体脂质纳米颗粒由于在聚合物的涂层下在酸性胃环境中是稳定的,因此即使口服给药,脂溶性药物的释放,因此脂溶性药物可以有效地用作口服施用脂溶性药物的制剂。

著录项

  • 公开/公告号KR101739194B1

    专利类型

  • 公开/公告日2017-05-23

    原文格式PDF

  • 申请/专利权人 가천대학교 산학협력단;

    申请/专利号KR20150117856

  • 发明设计人 고영탁;라말링감 프라카쉬;

    申请日2015-08-21

  • 分类号A61K9/14;A61K31/05;A61K47/36;A61K47/44;

  • 国家 KR

  • 入库时间 2022-08-21 13:25:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号